Aegon Sells UK Operations to Enhance Focus on U.S. Life Insurance
Aegon, the Netherlands-based international group specializing in life insurance, pensions, and asset management, has announced an agreement to sell its UK operations to Standard Life plc for £2.0 billion. This strategic move aims to bolster Aegon's focus on the U.S. life insurance and retirement market.
The transaction includes Aegon's 15.3% equity stake in Standard Life, comprising 181.1 million shares, coupled with a cash payment of £750 million. Any distribution from Aegon UK before the transaction's completion will reduce the cash payment. The valuation represents approximately 14.2 times the expected 2025 operating result after tax and 1.9 times the projected 2025 IFRS shareholders’ equity.
Aegon plans to use the proceeds from this deal to reduce debt and facilitate share buybacks. Financial targets for 2026 and 2027 will be updated post-sale, with expected growth projections remaining constant but adjusted from a new baseline. Projections indicate an annual increase of about five percent in operating results from 2025 to 2027, based on a pro forma range of €1.3 billion to €1.5 billion for 2025.
From 2026, Aegon anticipates around a five percent annual rise in free cash flow, reflecting the exclusion of the UK contribution and inclusion of income from their stake in Standard Life. Dividends per share are expected to increase by more than five percent annually. Aegon's UK asset management division will remain part of its global operations and play a vital partnership role with the new combined entity.
Impact on Group Solvency and Regulatory Considerations
The transaction is expected to reduce Aegon’s group solvency ratio by about five percentage points on a pro forma 2025 basis before any capital management strategies. Nonetheless, shareholders’ equity could rise by approximately €1.1 billion, despite a €0.1 billion reduction in valuation equity due to the loss of contractual service margin. The overall impact on group earnings is forecast to be positive, estimated at around €0.6 billion.
Aegon UK will cease contributing to the group's operating results or capital generation until the transaction concludes, with its IFRS performance recorded as other income or charges. The deal is anticipated to finalize by late 2026, pending regulatory approvals and customary conditions. After completion, Aegon will adhere to a lock-up period on acquired shares, lasting up to 18 months or until redomiciliation to the U.S. is complete.
Lard Friese, CEO of Aegon, stated, “The transaction is a significant milestone in our bid to be a leading U.S. life insurance and retirement group. The terms underscore our commitment to delivering value for shareholders, while our shareholding in Standard Life provides an opportunity for future value creation within the combined entity.” Standard Life’s CEO, Andy Briggs, commented, “Aegon UK aligns with our values centered on financial wellbeing. Together, our organizations will not only be stronger but will enhance customer outcomes and financial security in later life.”